background: The influence of fibroids on fertility is poorly understood. Submucosal and intramural fibroids that distort the endometrial cavity have been associated with decreased pregnancy rates (PRs) following IVF treatment. However, there is uncertainty about the effect of intramural fibroids that do not distort the endometrial cavity on IVF outcomes.
Introduction
Uterine fibroids occur in up to 30% of reproductive age women (Verkauf, 1992) and are more common in Afrocarribean women. Although most women affected with fibroids are fertile, fibroids may interfere with fertility secondary to anatomical distortion and alterations to the uterine environment (Hasan et al., 1990; Verkauf, 1992) , with the effect being dictated largely by the location and size of the fibroid (Ubaldi et al., 1995; Rackow and Arici, 2005) .
With regards to in vitro fertilization (IVF) treatment, submucosal and intramural fibroids that protrude into the endometrial cavity have been associated with decreased pregnancy rates (PRs) and implantation rates (IRs) (Narayan and Goswamy, 1994; Farhi et al., 1995; Varasteh et al., 1999; Bernard et al., 2000) . Studies have shown that IVF outcome is markedly improved in women with cavity-distorting submucosal fibroids following myomectomy (Narayan and Goswamy, 1994; Varasteh et al., 1999; Bernard et al., 2000; Hart et al., 2001; Surrey et al., 2005) . However, the effect of fibroids not distorting the uterine cavity on the outcome of IVF treatment remains poorly understood with studies yielding conflicting results. The conflicting results may be attributable to clinical heterogeneity between the studies such as differences in patient inclusion criteria, and methodological inconsistencies related to the design of the studies. We conducted a systematic review of studies evaluating the association between non-cavity-distorting intramural fibroids and IVF outcome, and attempted to explore the inconsistencies present in the literature.
Methods

Identification of literature
The following electronic databases were searched: MEDLINE (1950 to October 2008 , EMBASE (1980 to October 2008 , Cochrane Central Register of Controlled Trials and Web of Science (1990 to October 2008 . A combination of Medical Subject Headings (MeSH) and text words were used to generate two subsets of citations, one including studies of uterine fibroids ('uterine fibroids', 'leiomyomas', 'myomas') and the other including studies of in vitro fertilization and intracytoplasmic sperm injection ('in vitro fertilization', 'fertilization-in vitro', 'intracytoplasmic sperm injection', 'sperm injection intracytoplasmic', 'reproductive techniques assisted', 'embryo transfer' and 'embryo implantation'). These subsets were combined with 'AND' to generate a subset of citations relevant to our research question. The reference lists of all known primary and review articles were examined to identify cited articles not captured by electronic searches. Articles, which were frequently quoted, were used in the Science Citation Index to identify additional citations. We also made enquires about unpublished studies from researchers investigating in this field. No language restrictions were placed in any of our searches. The searches were conducted independently by S.K.S. and M.K.
Study selection and data extraction
Studies were selected if the target population was women undergoing IVF treatment with or without ICSI, and the exposure was the presence of non-cavity-distorting intramural fibroids in the study group and no fibroids in the control group (no exposure). Studies involving women with submucous fibroids or predominantly subserous fibroids were excluded. The primary outcome of interest was the live birth rate. We also reported on secondary outcome measures such as clinical PR, IR and miscarriage rate.
Studies were selected in a two-stage process. First, the titles and abstracts from the electronic searches were scrutinized by two reviewers independently (S.K.S. and M.K.) and full manuscripts of all citations that were likely to meet the predefined selection criteria were obtained. Secondly, final inclusion or exclusion decisions were made on examination of the full manuscripts. In cases of duplicates the most recent or the most complete publication was used. Any disagreements about inclusion were resolved by consensus or arbitration by a third reviewer (A.C.).
Two reviewers (S.K.S. and M.K.) completed the quality assessment (Berlin and Rennie, 1999) . The Newcastle-Ottawa Quality Assessment Scales for observational studies were implemented (Wells et al., 2000) . Items assessed included selection of cases/cohorts and controls, comparability and exposure/outcome. We used an arbitrary score based on the assumption of equal weight of all items included in the Newcastle-Ottawa Scale. This was used to give a quantitative appraisal of overall quality of the individual studies. The score ranged from 0 to 9, with a score of either 0 or 1 for each item. From each study, outcome data were extracted in 2 Â 2 tables by the two reviewers S.K.S. and M.K.
Statistical analysis
Relative risks from individual studies were meta-analysed using fixed effects model (Mantel and Haenszel, 1959) and random effects models as appropriate (DerSimonian and Laird, 1986) . Heterogeneity of the exposure effects was evaluated graphically using forest plots (Lewis and Clarke, 2001 ) and statistically using the I 2 statistic to quantify heterogeneity across studies (Higgins and Thompson, 2002) . Exploration of the causes of heterogeneity was planned using variation in features of population, exposure and study quality. We performed sensitivity analyses where possible and appropriate to address the clinical and methodological variations. To assess for publication bias we performed funnel plot analysis, using Egger's test to test for asymmetry for the primary outcome of live birth (Egger et al., 1997) . Statistical analyses were performed using RevMan 4.2 (Cochrane Collaboration, Oxford, UK) and Stata 8.0 (Stata Corp, TX, USA).
Results
The search strategy yielded 805 citations, all captured from electronic citations (Fig. 1 ). Of these, 704 publications were excluded as it was clear from the title that they did not fulfil the selection criteria. From the remaining 101 articles, 74 were excluded on the basis of the abstract. For the remaining 27 articles, we obtained full manuscripts, and following scrutiny of these, we identified 24 potentially relevant studies; three publications were excluded as they were either duplicates and/or the same data were used in other included studies (Healy, 2000; Hart et al., 2001; Oliveira et al., 2005) . From these 24 studies, five were excluded for the following reasons: one study included women with intramural and/or submucous fibroids and did not report data separately for women with only intramural fibroids (Gianaroli et al., 2005) ; two studies involved women with predominantly subserous fibroids (Seoud et al., 1992; Ramzy et al., 1998) ; one study did not specify whether the fibroids were intramural or subserous (Farhi et al., 1995) ; and another study was excluded as the aim of this study was to establish the impact of surgical removal of fibroids before IVF treatment where women in the treatment group had myomectomy and women in the control group did not have surgery (Bulletti et al., 2004) . Therefore the total number of studies included in the review was 19 (Fig. 1) . Of these studies, 18 studies were in English and one study was in Spanish (Manzo et al., 2006) ; 18 studies were full manuscripts and one was an abstract (Bozdag et al., 2009) , the full article of which is in press. We obtained as much information as possible from the authors of this manuscript so that we could include the study in our review. Non-cavity distorting intramural fibroids and IVF All of the 19 included studies were observational studies whereby the target population (women having IVF treatment), with or without non-cavity-distorting intramural fibroids (exposure) were followed up to the outcomes. The main characteristics of the 19 studies and the Newcastle-Ottawa Quality Assessment are presented in Tables I and II . Although all studies included women with either only or predominantly non-cavity-distorting intramural fibroids, the size and number of fibroids varied. The exclusion criteria also varied between the different studies (Table I ). In four of the studies (Dietterich et al., 2000; Wang and Check, 2004; Klatsky et al., 2007; Horcajadas et al., 2008) , the women had oocyte donation IVF treatment. The studies scored well on the Newcastle-Ottawa Quality Assessment Scale (Table II) ; 1 study had the maximum score of 9, 16 studies scored 8 and 2 studies scored 7. Funnel plot analysis indicated that publication and related biases were unlikely (Egger's test P ¼ 0.98, Fig. 2 ).
Primary outcome
Live birth rate
Pooling of results from 11 of the 19 studies that reported live birth as an outcome showed a statistically significant 21% relative reduction in live birth rate in women with non-cavity-distorting intramural fibroids compared with women without fibroids (RR ¼ 0.79, 95% CI: 0.70 -0.88, P , 0.0001, Fig. 3 ). The finding remained unaltered regardless of the statistical method for pooling, with fixed (Mantel and Haenszel, 1959) or random (DerSimonian and Laird, 1986) effects models. The I 2 value was 15.1% indicating little variability in live birth between the studies.
Meta-analysis of the eight studies in which the mean age of women was less than 37 years and of the four studies involving women having their first IVF treatment cycle and that reported live birth as an outcome showed a significant 25% relative reduction and a nonsignificant 23% relative reduction, respectively, in live birth rate in women with intramural fibroids (RR ¼ 0.75, 95% CI: 0.62 -0.89, P ¼ 0.001, Fig. 4 and RR ¼ 0.77, 95% CI: 0.59 -1.00, P ¼ 0.05, Fig. 5 ). The I 2 values were 31.9 and 52.4%, respectively, indicating significant heterogeneity. Pooled analysis of the two prospective studies that reported live birth as an outcome showed a 40% significant relative reduction in live birth rate in women with intramural fibroids (RR ¼ 0.60, 95% CI: 0.41 -0.87, P ¼ 0.007, Fig. 6 ). There was no inconsistency between the studies, as indicated by an I 2 value of 0%.
Secondary outcomes
Clinical PR
Pooling of results from 18 of the 19 studies that reported clinical pregnancy as an outcome showed a statistically significant 15% reduction in clinical PR in women with non-cavity-distorting intramural fibroids, following IVF treatment (RR ¼ 0.85, 95% CI: 0.77 -0.94, P ¼ 0.002, Fig. 7 ). There was significant inconsistency across studies as indicated by an I 2 value of 25.7%.
Meta-analysis of the 13 studies that reported clinical pregnancy as an outcome in which the mean age of the women was less than 37 years showed a significant 18% reduction in the clinical PR in women with intramural fibroids (RR ¼ 0.82, 95% CI: 0.73 -0.92, P ¼ 0.0005). The I 2 value was 11% indicating little variation among these studies for the outcome of clinical pregnancy. Meta-analysis of the six studies that included women having their first IVF treatment cycle showed a significant 16% relative reduction in the clinical PR in women with intramural fibroids (RR ¼ 0.84, 95% CI: 0.73 -0.96, P ¼ 0.009). The I 2 value was 22.3% indicating little variation among the studies.
Pooling of results of the four prospective studies that reported clinical PR as an outcome showed a 11% non-significant reduction in clinical PR in women with intramural fibroids following IVF treatment (RR ¼ 0.89, 95% CI: 0.68 -1.17, P ¼ 0.41). There was no inconsistency among these studies as indicated by an I 2 value of 0%.
Implantation rate
Meta-analysis for the secondary outcome of IR showed a statistically non-significant 13% reduction in IR in women with non-cavity-distorting intramural fibroids (RR ¼ 0.87, 95% CI: 0.73-1.03, P ¼ 0.11, Fig. 8 ). There was significant inconsistency across the nine relevant studies (I 2 ¼26.3%).
Meta-analysis of the six studies involving women with a mean age of less than 37 years and that reported IR as an outcome showed a significant 28% reduction in IR in women with intramural fibroids (RR ¼ 0.72, 95% CI: 0.59 -0.87, P ¼ 0.0006). The I 2 value was 0%
indicating statistical homogeneity across studies. Two of the six studies involving women having their first IVF treatment cycle reported IR as an outcome. Meta-analysis of the two studies showed a nonsignificant 16% reduction in IR in women with intramural fibroids (RR ¼ 0.84, 95% CI: 0.55 -1.29, P ¼ 0.42). The I 2 value was 0% indicating statistical homogeneity across these studies. Two prospective studies (Ng et al., 2005; Khalaf et al., 2006) reported IR as an outcome. The results of these two studies could not be pooled as one of the studies reported the outcome in terms of odds ratio (Khalaf et al., 2006) . Both studies showed a trend towards a reduction in IR in women with intramural fibroids following IVF treatment, although the individual results were not statistically significant.
Miscarriage rate
Pooling of all studies that reported miscarriage as an outcome showed a statistically non-significant 24% relative increase in miscarriage rate in women with non-cavity-distorting intramural fibroids, following IVF treatment (RR ¼ 1.24, 95% CI: 0.99-1.57, P ¼ 0.07, Fig. 9 ). There was little inconsistency across studies with an I 2 value of 11.1%.
Meta-analysis of the 10 studies that reported miscarriage as an outcome in which the mean age of women was less than 37 years and of the six studies involving women having their first IVF treatment cycle showed non-significant 5 and 15% relative increases, respectively, in the miscarriage rate in women with intramural fibroids (RR ¼ 1.05, 95% CI: 0.80 -1.39, P ¼ 0.73 and RR ¼ 1.15, 95% CI: 0.82 -1.60, P ¼ 0.43 respectively). The I 2 value was 0% in both the analyses indicating statistical homogeneity across studies. Meta-analysis of the three prospective studies that reported miscarriage as an outcome showed a 10% non-significant relative increase in miscarriage rate in women with intramural fibroids (RR ¼ Women with previous myomectomy, uterine cavity abnormalities, uterine cavity distortion by fibroids or prior pregnancy through treatment at the study centre.
Study group (n ¼ 9), with non-cavity-distorting intramural fibroids. Controls (n ¼ 11).
Fibroids size ranging from 0.6 to 2.6 cm. Number of fibroids ranging from 1 to 6. (Khaund and Lumsden, 2008; Klatsky et al., 2008) . The inverse relationship between IVF outcome and the presence of non-cavity distorting intramural fibroid may be explained by altered uterine vascular perfusion, myometrial contractility, endometrial function, gamete migration or myometrial/endometrial gene expression (Arslan et al., 2005; Ng et al., 2005; Nishino et al., 2005; Pritts et al., 2009) . Previous reviews have addressed the relationship between intramural fibroids and outcome of IVF treatment (Somigliana et al., 2007; Klatsky et al., 2008; Pritts et al., 2009) . The results of our systematic review are concordant with the findings of the recent updated review by Pritts et al. (2009) which addressed the impact of submucosal, intramural and subserosal fibroids on fertility. Our review represents the first attempt to extensively review the literature and provide a quantitative estimate of the relationship between non-cavity distorting intramural fibroids and IVF outcome.
IR
The strength of our review lies in the extensive search strategy and valid data synthesis methods. We also contacted authors of the primary studies for clarification of relevant information. We performed a funnel plot analysis to assess the publication bias. The funnel plot was symmetrical, indicating that publication and related biases were unlikely. The validity of our results is also directly related to the quality of the primary studies selected through our search. We used the Newcastle-Ottawa Quality Assessment Scale to rate the quality of the included studies (Table II) . Individual studies scored well on the Quality Assessment Scale. The studies included varied in the design; 14 of the 19 studies were retrospective studies and 5 were prospective studies (Table I) .
The weaknesses in our review are mainly related to the clinical heterogeneity among the studies. For example the nature of IVF treatment provided varied amongst the primary studies, with six studies assessing the impact of intramural fibroids on the first IVF/ ICSI cycle (Stovall et al., 1998; Jun et al. 2001; Check et al., 2002; Nejad et al., 2007; Yarali and Bukulmez 2002; Oliveira et al., 2004) , four other studies examined the effect of intramural fibroids in oocyte donation cycles (Dietterich et al., 2000; Wang and Check, 2004; Klatsky et al., 2007; Horcajadas et al., 2008) and one study reporting the cumulative IVF outcome after a maximum of three IVF/ICSI cycles (Khalaf et al., 2006) . Studies also differed in the diagnostic methods used to ascertain normality of the uterine cavity. Whilst some studies used ultrasound scan only, others used additional Figure 8 Forest plot of studies of non-cavity-distorting intramural fibroids versus no fibroids in women undergoing IVF treatment for outcome of IRs. Figure 9 Forest plot of studies of non-cavity-distorting intramural fibroids versus no fibroids in women undergoing IVF treatment for outcome of miscarriage rates.
Non-cavity distorting intramural fibroids and IVF hysterosonography, hysterosalpingography or hysteroscopy to exclude uterine cavity distortion. The mean size and number of fibroids also varied across the studies. Moreover, whereas some studies excluded women with previous myomectomy, others did not mention excluding them, and one study (Jun et al., 2001) included women with previous myomectomy and no fibroids on ultrasound scan in the control group.
To address the clinical heterogeneity, we performed multiple sensitivity analyses based on age, order of treatment cycle and design of study for both primary and secondary outcomes. Meta-analysis of studies that involved women with mean age less than 37 years showed an adverse effect on pregnancy outcomes in women with intramural fibroids following IVF treatment. Meta-analysis of studies only involving women having their first IVF treatment cycle was also consistent in showing a negative impact on pregnancy outcomes. Meta-analysis of only the prospective studies also showed an adverse pregnancy outcome following IVF treatment in women with intramural fibroids compared with women without fibroids, with a 40% significant reduction in live birth rate.
In conclusion, although this review of observational studies found a reduced chance of IVF success associated with the presence of non-cavity-distorting intramural fibroids, it should be acknowledged that observational studies are fraught with potential biases and confounders. Moreover, demonstration of reduction in IVF live births in women with non-cavity-distorting intramural fibroids does not necessarily mean that removal of such fibroids will restore the live birth rates to the levels expected in women without fibroids. Therefore this evidence does not justify advocating routine myomectomy for these women, as a favourable risk benefit analysis of this surgical intervention or any other interventions, in this clinical context is currently lacking. A well designed randomized controlled trial is therefore needed to address this question and generate the best evidence overcoming the pitfalls of observational studies.
